Zynerba: Q1 Earnings Snapshot

·1 min read

DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Wednesday reported a loss of $8 million in its first quarter.

On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 20 cents.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 24 cents per share.

The company's shares closed at $4.16. A year ago, they were trading at $4.45.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting